This role is responsible for developing and implementing biomarker strategies to support the clinical development of late-stage oncology assets.
Base: $189,750 to $316,250; Bonus/Equity: Annual bonus and share-based long term incentive program eligible; Benefits: Health care, retirement, paid holidays, vacation, and parental leave
Must-have
Nice-to-have
Not specified